Eckert & Ziegler Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 1,100

Employees

  • Stock Symbol
  • EUZ

Stock Symbol

  • Investments
  • 36

  • Share Price
  • $15.88
  • (As of Friday Closing)

Eckert & Ziegler General Information

Description

Eckert & Ziegler SE is a holding company with specialised in the processing of radioisotopes and the development, production and sale of isotope technology components, radiopharmaceuticals and related products. It is an international manufacturer of isotope technology components for medical, scientific, and industrial applications. The group's products are mainly used in cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The majority of revenue comes from Medical segment which provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. Geographically, the company generates a majority of its revenue from Europe and then North America, Asia/Pacific, and other.

Contact Information

Website
www.ezag.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Robert-Rössle-Street.10
  • 13125 Berlin
  • Germany
+49 030
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Industrial Supplies and Parts
Stock Exchange
ETR
Corporate Office
  • Robert-Rössle-Street.10
  • 13125 Berlin
  • Germany
+49 030

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eckert & Ziegler Stock Performance

As of 20-Nov-2026, Eckert & Ziegler’s stock price is $15.88. Its current market cap is $994M with 62.6M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$15.88 $16.18 $13.40 - $19.62 $994M 62.6M 107K $1.01

Eckert & Ziegler Financials Summary

As of 30-Sep-2026, Eckert & Ziegler has a trailing 12-month revenue of $368M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 827,016 1,038,129 921,624 925,378
Revenue 368,086 351,893 320,139 266,290
EBITDA 111,251 102,441 85,274 63,655
Net Income 63,144 55,005 36,008 28,459
Total Assets 563,121 537,889 460,345 485,673
Total Debt 43,850 52,629 57,584 62,238
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Eckert & Ziegler Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Eckert & Ziegler‘s full profile, request access.

Request a free trial

Eckert & Ziegler Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Eckert & Ziegler SE is a holding company with specialised in the processing of radioisotopes and the development, produc
Diagnostic Equipment
Berlin, Germany
1,100 As of 2026

Hercules, CA
 

Billerica, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eckert & Ziegler Competitors (8)

One of Eckert & Ziegler’s 8 competitors is Bio-Rad Laboratories, a Corporation company based in Hercules, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bio-Rad Laboratories Corporation Hercules, CA
Bruker Formerly VC-backed Billerica, MA
W. L. Gore and Associates Private Debt Financed Newark, DE
Ion Beam Applications Corporation Louvain-La-Neuve, Belgium
Guerbet Group Corporation Villepinte, France
You’re viewing 5 of 8 competitors. Get the full list »

Eckert & Ziegler Patents

Eckert & Ziegler Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2543412-A1 Emitter points module for an afterloader and afterloader system with afterloader and emitter points module Inactive 05-Jul-2011
ES-2375927-T3 Apparatus and system for combining links that include radioactive sources until forming a chain. Active 12-Feb-2010
EP-2359904-A1 Cartridge for chain components of a chain with radioactive radiation sources and a system comprising a chain component and a cartridge Active 12-Feb-2010
EP-2359904-B1 Cartridge for chain components of a chain with radioactive radiation sources and a system comprising a chain component and a cartridge Inactive 12-Feb-2010
JP-2011161237-A Device and system for assembling chain component to form chain Pending 12-Feb-2010 A61N5/1001
To view Eckert & Ziegler’s complete patent history, request access »

Eckert & Ziegler Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eckert & Ziegler Investments & Acquisitions (36)

Eckert & Ziegler’s most recent deal was a Joint Venture with Radioisotopes Production (Eckert & Ziegler Strahlen- und Medizintechnik / DC Pharma) for . The deal was made on 14-Nov-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Radioisotopes Production (Eckert & Ziegler Strahlen- und Medizintechnik / DC Pharma) 14-Nov-2023 Joint Venture Other Energy
Myelo Therapeutics 15-Dec-2022 Merger/Acquisition Drug Discovery
Pentixapharm 16-Apr-2021 Merger/Acquisition Drug Discovery
Qikangyuan 15-Apr-2021 Joint Venture Pharmaceuticals
Myelo Therapeutics 26-Jun-2020 Later Stage VC Drug Discovery
You’re viewing 5 of 36 investments and acquisitions. Get the full list »

Eckert & Ziegler ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

28.76 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Eckert & Ziegler’s complete esg history, request access »

Eckert & Ziegler Exits (5)

Eckert & Ziegler’s most recent exit was on 16-Apr-2021 from Pentixapharm. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Pentixapharm 16-Apr-2021 Completed
TCL Eckert & Ziegler BEBIG Healthcare 01-Aug-2019 Completed
  • 2 buyers
Curasight 01-Feb-2016 Completed
OctreoPharm Sciences 22-Jul-2013 Completed
Analytics (Minnesota) 11-Aug-2005 Merger/Acquisition Completed
To view Eckert & Ziegler’s complete exits history, request access »

Eckert & Ziegler Affiliates

Subsidiaries (6)

Name Industry Location Year Founded
Myelo Therapeutics Berlin, Germany 2013
nuclitec Brunswick, Germany 1998
Gamma-Service Recycling Leipzig, Germany 1998
Eckert & Ziegler f-con Europe Berlin, Germany 1995
Eckert & Ziegler Chemotrade Dusseldorf, Germany 1992
You’re viewing 5 of 6 affiliates. Get the full list.  »

Eckert & Ziegler FAQs

  • When was Eckert & Ziegler founded?

    Eckert & Ziegler was founded in 1997.

  • Where is Eckert & Ziegler headquartered?

    Eckert & Ziegler is headquartered in Berlin, Germany.

  • What is the size of Eckert & Ziegler?

    Eckert & Ziegler has 1,100 total employees.

  • What industry is Eckert & Ziegler in?

    Eckert & Ziegler’s primary industry is Diagnostic Equipment.

  • Is Eckert & Ziegler a private or public company?

    Eckert & Ziegler is a Public company.

  • What is Eckert & Ziegler’s stock symbol?

    The ticker symbol for Eckert & Ziegler is EUZ.

  • What is the current stock price of Eckert & Ziegler?

    As of 20-Nov-2026 the stock price of Eckert & Ziegler is $15.88.

  • What is the current market cap of Eckert & Ziegler?

    The current market capitalization of Eckert & Ziegler is $994M.

  • What is Eckert & Ziegler’s current revenue?

    The trailing twelve month revenue for Eckert & Ziegler is $368M.

  • Who are Eckert & Ziegler’s competitors?

    Bio-Rad Laboratories, Bruker, W. L. Gore and Associates, Ion Beam Applications, and Guerbet Group are some of the 8 competitors of Eckert & Ziegler.

  • What is Eckert & Ziegler’s annual earnings per share (EPS)?

    Eckert & Ziegler’s EPS for 12 months was $1.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process